Image Guided Surgery Market Poised for Strong Growth, Hitting USD 21,386 Million by 2035

Image Guided Surgery (IGS) Devices Market, valued at USD 7,985 million in 2024, is projected to surge to USD 21,386 million by 2035, achieving a robust CAGR of 7%. Driven by the rising demand for minimally invasive surgeries, advancements in imaging technologies, and increasing prevalence of chronic diseases, this market is revolutionizing surgical precision and patient outcomes. This press release explores key growth drivers, projections, and opportunities for stakeholders in this transformative healthcare sector.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4814

Why Is the Market Growing?

The Image Guided Surgery Devices Market is expanding due to the growing adoption of minimally invasive procedures, which reduce recovery times and complications by up to 30%, according to industry studies. Advanced imaging technologies like CT scanners, MRI, and ultrasound, combined with AI and augmented reality, enhance surgical precision in neurosurgery, oncology, and cardiovascular procedures.

The rising incidence of chronic diseases, such as cancer (20 million new cases globally in 2022) and neurological disorders, fuels demand for IGS devices, particularly in neurosurgery, which held a 29% market share in 2021. Regulatory support, including FDA's fast-track approvals for innovative devices, and increasing healthcare investments in emerging economies like China, where minimally invasive surgeries grew 10% in 2024, drive growth. Challenges like high device costs, averaging USD 500,000 per system, are being addressed through AI-driven cost optimization and modular designs.

What Are the Key Market Projections?

The market is expected to grow from USD 7,985 million in 2024 to USD 21,386 million by 2035, with a 7% CAGR, creating a USD 12,100 million opportunity, matching the growth from 2020 to 2024 at a 3% CAGR. Neurosurgery applications are projected to grow at a 6% CAGR, generating a USD 4,161 million opportunity by 2035, while devices like CT scanners and ultrasound systems held a 75% revenue share in 2021. North America, with a 44.9% share in 2021, is estimated to hold 35% in 2035, while North America and East Asia collectively create a USD 7,046 million opportunity. The historical CAGR from 2020 to 2024 was 3%, reflecting resilience despite COVID-19 disruptions. Short-term growth (2025-2028) will focus on oncology, while long-term trends (2032-2035) emphasize AI-integrated systems.

How Can Stakeholders Leverage Opportunities?

Stakeholders in healthcare, medical technology, and hospitals can capitalize on the market's growth by investing in AI-integrated and AR-enhanced IGS devices. Medical device manufacturers can develop cost-effective, modular systems for emerging markets like East Asia, where China's demand for minimally invasive surgeries is rising. Hospitals, which held a 75% end-user share in 2021, can adopt IGS for neurosurgery and oncology to reduce complications by 20%. Strategic partnerships, like Stryker's 2021 acquisition of Gauss Surgical's AI-enabled TritonTM platform, enhance innovation. Targeting North America, with its robust healthcare infrastructure, and East Asia, with growing investments, offers significant potential. Developing affordable devices and leveraging real-world data integration, as seen with Philips' ClarifEye AR system, ensures compliance with regulatory standards and improves patient outcomes.

What Does the Report Cover?

Fact.MR's report combines primary research with industry experts and secondary analysis of market trends. It covers market segments by product (CT scanners, ultrasound systems, MRI, endoscopes, X-ray fluoroscopy, PET, SPECT), application (neurosurgery, cardiac surgery, orthopedic surgery, oncology, others), end user (hospitals, ambulatory surgical centers, clinics), and region (North America, Latin America, Europe, East Asia, South Asia & Oceania, Middle East & Africa). The report highlights trends like AI integration, minimally invasive surgery demand, and regulatory advancements, providing actionable insights for stakeholders to navigate market opportunities and drive innovation.

Browse Full Report: https://www.factmr.com/report/4814/image-guided-surgery-devices-market

Who Are the Market Leaders?

Key players include Stryker Corporation, Koninklijke Philips N.V., Siemens Healthineers, GE Healthcare, Medtronic Plc, Brainlab AG, and Erbe Elektromedizin GmbH. In September 2021, Stryker acquired Gauss Surgical, enhancing its AI-driven TritonTM platform for blood loss monitoring. Philips introduced ClarifEye AR surgical navigation in February 2021, improving spinal surgery precision. Erbe Elektromedizin acquired Maxer Endoscopy in April 2021, expanding its imaging portfolio. These companies, holding over 50% of the market share, are driving innovation through acquisitions, new product launches, and collaborations with healthcare institutions.

What Are the Latest Market Developments?

In 2024, AI-integrated IGS devices gained traction, with systems like Philips' ClarifEye reducing X-ray doses by 50% in spinal surgeries. North America's market grew, with 70% of 2024 FDA approvals targeting IGS technologies. East Asia saw a 10% rise in minimally invasive procedures, driven by China's healthcare investments. In 2023, Crouse Health adopted Mako SmartRobotics for orthopedic surgeries, enhancing precision by 15%. Regulatory advancements, like the EU's Medical Device Regulation, supported eco-friendly manufacturing, while innovations in 3D and 4D ultrasound improved procedural accuracy by 20%. The rising prevalence of traumatic brain injuries, with 69,473 U.S. fatalities in 2021, further boosted demand for neurosurgery-focused IGS devices.

What Challenges and Solutions Exist?

High device costs, averaging USD 500,000, and complex integration with existing surgical workflows pose challenges. Supply chain disruptions, impacting 80% of manufacturers during COVID-19, persist as a concern. Solutions include developing cost-effective, modular IGS systems, as pursued by Siemens Healthineers, reducing costs by 15%. Partnerships with hospitals, like Medtronic's 2024 collaboration with academic medical centers, streamline integration. Localized production in high-growth regions like East Asia mitigates supply chain risks. AI-driven analytics and cloud-based imaging solutions, as seen with GE Healthcare, enhance efficiency and compliance with FDA and EU standards, ensuring market resilience.

Conclusion:

The Global Image Guided Surgery Devices Market is set to reach USD 21,386 million by 2035, driven by a 7% CAGR. With applications in neurosurgery, oncology, and cardiac surgery, and supported by AI and AR innovations, the market offers transformative opportunities. Stakeholders can leverage Fact.MR's insights to target high-growth regions like North America and East Asia, invest in cost-effective technologies, and address integration challenges to thrive in this cutting-edge healthcare sector.

Check out More Related Studies Published by Fact.MR:

Medical Image Exchange System Market: https://www.factmr.com/report/medical-image-exchange-system-market

Minimally Invasive Surgery Market: https://www.factmr.com/report/minimally-invasive-surgery-market

Computer-Assisted Orthopedic Surgery Market: https://www.factmr.com/report/computer-assisted-orthopedic-surgery-market

Cosmetic Surgery and Procedure Market: https://www.factmr.com/report/cosmetic-surgery-and-procedure-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.